Mass General Brigham researchers are shining a powerful new light into the viral darkness with the development of ...

A team of scientists at NYU Abu Dhabi has developed a breakthrough paper-based diagnostic device that can detect COVID-19 and ...

Researchers compared their long-standing diagnostic decision support systems AI tool, DXplain, with modern large language models like ChatGPT and Gemini, finding DXplain performed slightly better.

Antoine de Sagey, director of diagnostics tools at Owkin, spoke with pharmaphorum about PULS-AI’s patient outcome prediction, citing the company’s earlier deep learning tool MesoNet’s ...

The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio, from Fujirebio Diagnostics, Inc., is for the early detection of amyloid plaques associated with AD in adults aged 55 years and older who ...

Innovation in clinical diagnostics is accelerating, with breakthroughs that promise to make testing more precise, less invasive and more accessible. These advancements are expected not only to benefit ...

As part of our worldwide commitment to improve the diagnosis and treatment of AD, Fujirebio is developing additional assays, which will increase the availability of diagnostic tools and expand the ...

The two plan to collaborate on developing AI solutions and making powerful computing tools, like GPUs, more accessible to African developers. In theory, this could be a big deal. Training modern ...

Rollout plans for the company’s early dementia detection software in the US follow the tool’s FDA clearance in January 2025.

If you find Google's live translation tools useful, you'll soon be able to use them more naturally during video calls and meetings. The company announced today at its I/O developer conference that ...